347 related articles for article (PubMed ID: 18257430)
1. [Use of SSRIs during pregnancy and possible consequences for the development of the child].
van der Veere CN; Bos AF
Ned Tijdschr Geneeskd; 2007 Dec; 151(52):2873-4. PubMed ID: 18257430
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
[TBL] [Abstract][Full Text] [Related]
3. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.
Oberlander TF; Warburton W; Misri S; Aghajanian J; Hertzman C
Arch Gen Psychiatry; 2006 Aug; 63(8):898-906. PubMed ID: 16894066
[TBL] [Abstract][Full Text] [Related]
4. Fluoxetine during pregnancy: impact on fetal development.
Morrison JL; Riggs KW; Rurak DW
Reprod Fertil Dev; 2005; 17(6):641-50. PubMed ID: 16263070
[TBL] [Abstract][Full Text] [Related]
5. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B
Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923
[TBL] [Abstract][Full Text] [Related]
6. SSRI antidepressants and persistent pulmonary hypertension in newborns.
Prescrire Int; 2008 Aug; 17(96):156. PubMed ID: 19492488
[TBL] [Abstract][Full Text] [Related]
7. Prenatal SSRI exposure: Effects on later child development.
Hermansen TK; Melinder A
Child Neuropsychol; 2015; 21(5):543-69. PubMed ID: 25089614
[TBL] [Abstract][Full Text] [Related]
8. Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes.
El Marroun H; Jaddoe VW; Hudziak JJ; Roza SJ; Steegers EA; Hofman A; Verhulst FC; White TJ; Stricker BH; Tiemeier H
Arch Gen Psychiatry; 2012 Jul; 69(7):706-14. PubMed ID: 22393202
[TBL] [Abstract][Full Text] [Related]
9. Maternal use of SSRIs, SNRIs and NaSSAs: practical recommendations during pregnancy and lactation.
Sie SD; Wennink JM; van Driel JJ; te Winkel AG; Boer K; Casteelen G; van Weissenbruch MM
Arch Dis Child Fetal Neonatal Ed; 2012 Nov; 97(6):F472-6. PubMed ID: 23080479
[TBL] [Abstract][Full Text] [Related]
10. Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring.
Brown AS; Gyllenberg D; Malm H; McKeague IW; Hinkka-Yli-Salomäki S; Artama M; Gissler M; Cheslack-Postava K; Weissman MM; Gingrich JA; Sourander A
JAMA Psychiatry; 2016 Nov; 73(11):1163-1170. PubMed ID: 27732704
[TBL] [Abstract][Full Text] [Related]
11. Perinatal selective serotonin reuptake inhibitor exposure: impact on brain development and neural plasticity.
Pawluski JL
Neuroendocrinology; 2012; 95(1):39-46. PubMed ID: 21893935
[TBL] [Abstract][Full Text] [Related]
12. Prenatal exposure to selective serotonin reuptake inhibitors and childhood overweight at 7 years of age.
Grzeskowiak LE; Gilbert AL; Sørensen TI; Olsen J; Sørensen HT; Pedersen LH; Morrison JL
Ann Epidemiol; 2013 Nov; 23(11):681-7. PubMed ID: 24113367
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.
Oberlander TF; Misri S; Fitzgerald CE; Kostaras X; Rurak D; Riggs W
J Clin Psychiatry; 2004 Feb; 65(2):230-7. PubMed ID: 15003078
[TBL] [Abstract][Full Text] [Related]
14. Early morbidity and mortality following in utero exposure to selective serotonin reuptake inhibitors: a population-based study in Western Australia.
Colvin L; Slack-Smith L; Stanley FJ; Bower C
CNS Drugs; 2012 Jul; 26(7):e1-14. PubMed ID: 22712699
[TBL] [Abstract][Full Text] [Related]
15. Prenatal Antidepressant Exposure and Offspring Brain Morphologic Trajectory.
Koc D; Tiemeier H; Stricker BH; Muetzel RL; Hillegers M; El Marroun H
JAMA Psychiatry; 2023 Dec; 80(12):1208-1217. PubMed ID: 37647036
[TBL] [Abstract][Full Text] [Related]
16. The Roles of Maternal Depression, Serotonin Reuptake Inhibitor Treatment, and Concomitant Benzodiazepine Use on Infant Neurobehavioral Functioning Over the First Postnatal Month.
Salisbury AL; O'Grady KE; Battle CL; Wisner KL; Anderson GM; Stroud LR; Miller-Loncar CL; Young ME; Lester BM
Am J Psychiatry; 2016 Feb; 173(2):147-57. PubMed ID: 26514656
[TBL] [Abstract][Full Text] [Related]
17. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
Singal D; Brownell M; Chateau D; Ruth C; Katz LY
BMJ Open; 2016 Nov; 6(11):e013293. PubMed ID: 27899401
[TBL] [Abstract][Full Text] [Related]
18. Selective serotonin reuptake inhibitor use during pregnancy and possible neonatal complications.
Cantor Sackett J; Weller RA; Weller EB
Curr Psychiatry Rep; 2009 Jun; 11(3):253-7. PubMed ID: 19470288
[TBL] [Abstract][Full Text] [Related]
19. Hub distribution of the brain functional networks of newborns prenatally exposed to maternal depression and SSRI antidepressants.
Rotem-Kohavi N; Williams LJ; Muller AM; Abdi H; Virji-Babul N; Bjornson BH; Brain U; Werker JF; Grunau RE; Miller SP; Oberlander TF
Depress Anxiety; 2019 Aug; 36(8):753-765. PubMed ID: 31066992
[TBL] [Abstract][Full Text] [Related]
20. Does fetal exposure to SSRIs or maternal depression impact infant growth?
Wisner KL; Bogen DL; Sit D; McShea M; Hughes C; Rizzo D; Confer A; Luther J; Eng H; Wisniewski SW
Am J Psychiatry; 2013 May; 170(5):485-93. PubMed ID: 23511234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
